Michael S. Gunter is Interim CEO at ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ (HRT). They have made 8 open-market trades across 2 companies since 2011, most recently 2012-12-18.
CIK 0001504240
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
7 open-market purchases totalling $43K since 2011, against 1 sale. Across 7 scored buys the stock is up 0.0% at ninety days, and 0.3 points behind the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 0% | 0% |
| Avg Move | -2.8% | +0.0% | +0.0% |
| Alpha | +3.1% | -0.3% | -0.3% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HRT | BUY | 2012-12-17 | 2012-12-19 | $2.62 | $13K | -2.8% | +0.0% | +0.0% |
| HRT | BUY | 2012-12-05 | 2012-12-10 | $2.57 | $13K | -2.8% | +0.0% | +0.0% |
| HRT | BUY | 2012-12-03 | 2012-12-10 | $2.39 | $239 | -2.8% | +0.0% | +0.0% |
| HRT | BUY | 2011-12-13 | 2011-12-15 | $3.20 | $2K | -2.8% | +0.0% | +0.0% |
| HRT | BUY | 2011-11-29 | 2011-11-30 | $3.40 | $8K | -2.8% | +0.0% | +0.0% |
| HRT | BUY | 2011-09-14 | 2011-09-15 | $3.58 | $6K | -2.8% | +0.0% | +0.0% |
| PRMW | SELL | 2011-06-22 | 2011-06-23 | $11.26 | $82K | +8.5% | +3.2% | +3.2% |
| HRT | BUY | 2011-06-13 | 2012-02-14 | $4.85 | $1K | -2.8% | +0.0% | +0.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.